COMPANY PROFILE // THE 014 REPORT
Cidara Therapeutics, Inc.
Formerly: K2 THERAPEUTICS, INC.
Assembled from 1 government source in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-01-07 (last 24 months).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Cidara Therapeutics, Inc. is an SEC-registered operating company in biological products, (no diagnostic substances), incorporated in DE, based in San Diego, CA.[source] It reported revenue of $1.3 million for the fiscal year ended 2024-12-31.[source] It has filed 61 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-02-17.[source] Seraphix flags 1 item from these records: 8-K Item 3.01 filed.[source]
- red0
- amber1
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001610618 | source |
| EIN | 46-1537286 | source |
| Business address (SEC) | 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA, 92121 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 129 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 174 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.
Peers, each with its 014
- AMGEN INC · 123 SEC filings in 12 months · 1 flag · $507.4M federal (possible match)
- Vir Biotechnology, Inc. · 117 SEC filings in 12 months · 1 flag · $65.9M federal (possible match)
- Vericel Corp · 109 SEC filings in 12 months · 1 flag · $37.3M federal (possible match)
- Coherus Oncology, Inc. · 53 SEC filings in 12 months · 3 flags · $11.8M federal (possible match)
- BIO-TECHNE Corp · 77 SEC filings in 12 months · 1 flag · $6.6M federal (possible match)
- Twist Bioscience Corp · 337 SEC filings in 12 months · 2 flags · $5.9M federal (possible match)
- Adaptive Biotechnologies Corp · 185 SEC filings in 12 months · 1 flag · $1.9M federal (possible match)
- AGENUS INC · 82 SEC filings in 12 months · 3 flags · $613K federal (possible match)
- REPLIGEN CORP · 89 SEC filings in 12 months · 1 flag · $457K federal (possible match)
- Revolution Medicines, Inc. · 171 SEC filings in 12 months · 2 flags · $15K federal (possible match)
- RECURSION PHARMACEUTICALS, INC. · 174 SEC filings in 12 months · 1 flag
- GILEAD SCIENCES, INC. · 173 SEC filings in 12 months
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-01-20 filing 15-12G · SEC EDGAR
- 2026-01-09 filing EFFECT · SEC EDGAR
- 2026-01-09 filing EFFECT · SEC EDGAR
- 2026-01-09 filing EFFECT · SEC EDGAR
- 2026-01-09 filing EFFECT · SEC EDGAR
- 2026-01-09 filing EFFECT · SEC EDGAR
- 2026-01-09 filing EFFECT · SEC EDGAR
- 2026-01-09 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing S-8 POS · SEC EDGAR
- 2026-01-07 filing POS AM · SEC EDGAR
- 2026-01-07 filing POS AM · SEC EDGAR
- 2026-01-07 filing POS AM · SEC EDGAR
- 2026-01-07 filing POS AM · SEC EDGAR
- 2026-01-07 filing POS AM · SEC EDGAR
- 2026-01-07 filing POS AM · SEC EDGAR
- 2026-01-07 filing 25-NSE · SEC EDGAR
- 2026-01-07 officer change 8-K items 1.02,2.01,3.01,3.03,5.01,5.02,5.03,9.01 · SEC EDGAR
169 earlier entries
- 2026-01-07 filing SC 14D9/A
- 2026-01-07 filing SC TO-T/A
- 2025-12-19 filing SC 14D9/A
- 2025-12-19 filing SC TO-T/A
- 2025-12-17 filing SC TO-T/A
- 2025-12-05 filing SC 14D9
- 2025-12-05 filing SC TO-T
- 2025-11-17 filing SCHEDULE 13D/A
- 2025-11-14 filing SC14D9C
- 2025-11-14 filing 8-K items 1.01,7.01,9.01
- 2025-11-14 filing SC TO-C
- 2025-11-10 filing SCHEDULE 13D/A
- 2025-11-06 filing Quarterly report (10-Q)
- 2025-11-06 filing 8-K items 2.02,9.01
- 2025-10-06 filing 8-K items 1.01
- 2025-09-24 filing 8-K items 8.01
- 2025-09-04 filing UPLOAD
- 2025-08-26 filing CORRESP
- 2025-08-13 filing UPLOAD
- 2025-08-11 filing SCHEDULE 13D/A
- 2025-08-07 filing S-8
- 2025-08-07 filing Quarterly report (10-Q)
- 2025-08-07 filing 8-K items 2.02,9.01
- 2025-06-30 filing SCHEDULE 13D/A
- 2025-06-25 filing 8-K items 8.01,9.01
- 2025-06-25 filing 424B5
- 2025-06-24 filing 8-K items 8.01
- 2025-06-23 filing 424B5
- 2025-06-23 filing 8-K items 8.01,9.01
- 2025-06-20 officer change 8-K items 5.02,5.03,5.07,9.01
- 2025-05-15 filing EFFECT
- 2025-05-13 filing CORRESP
- 2025-05-13 filing UPLOAD
- 2025-05-08 filing S-3
- 2025-05-08 filing Quarterly report (10-Q)
- 2025-05-08 filing 8-K items 2.02,9.01
- 2025-04-25 filing ARS
- 2025-04-25 filing DEFA14A
- 2025-04-25 filing Proxy statement
- 2025-04-15 filing PRE 14A
- 2025-03-06 filing S-8
- 2025-03-06 filing 8-K items 2.02,9.01
- 2025-03-06 filing Annual report (10-K)
- 2025-02-18 officer change 8-K items 5.02,9.01
- 2025-01-07 officer change 8-K items 5.02,9.01
- 2025-01-02 filing 424B3
- 2024-12-31 filing EFFECT
- 2024-12-30 filing CORRESP
- 2024-12-30 filing UPLOAD
- 2024-12-23 filing Registration (S-1)
- 2024-11-26 filing SC 13D/A
- 2024-11-26 filing 8-K items 1.01,3.02,8.01,9.01
- 2024-11-07 filing 8-K items 2.02,9.01
- 2024-11-07 filing Quarterly report (10-Q)
- 2024-09-23 filing 8-K items 8.01
- 2024-09-12 filing 8-K items 2.05,8.01
- 2024-08-13 filing S-8
- 2024-08-13 filing 8-K items 2.02,9.01
- 2024-08-13 filing Quarterly report (10-Q)
- 2024-07-31 filing EFFECT
- 2024-07-31 filing 424B3
- 2024-07-29 filing CORRESP
- 2024-07-29 filing UPLOAD
- 2024-07-25 filing SC 13D
- 2024-07-19 filing Registration (S-1)
- 2024-07-18 officer change 8-K items 5.02,5.03,5.07,9.01
- 2024-06-03 filing ARS
- 2024-06-03 filing DEFA14A
- 2024-06-03 filing Proxy statement
- 2024-05-23 filing PRE 14A
- 2024-05-20 officer change 8-K items 5.02
- 2024-05-15 filing 8-K items 2.02,9.01
- 2024-05-15 filing Quarterly report (10-Q)
- 2024-05-06 filing D
- 2024-05-03 filing 8-K items 8.01,9.01
- 2024-04-29 filing 8-K/A items 1.01,1.02,2.01,9.01
- 2024-04-24 officer change 8-K items 1.01,1.02,3.02,5.02,5.03,9.01
- 2024-04-24 filing 8-K items 1.01,1.02,2.01
- 2024-04-23 filing S-8
- 2024-04-22 filing 8-K items 2.02,3.03,5.03,9.01
- 2024-04-22 filing Annual report (10-K)
- 2024-04-16 filing 8-K items 4.02
- 2024-04-05 filing 8-K items 5.07
- 2024-04-01 filing NT 10-K
- 2024-03-04 filing Proxy statement
- 2024-02-23 filing PRE 14A
- 2024-02-09 filing 8-K items 8.01
- 2023-12-22 filing 8-K items 8.01
- 2023-11-17 filing 8-K items 8.01
- 2023-11-16 filing 8-K items 3.01
- 2023-11-02 filing 8-K items 2.02,9.01
- 2023-11-02 filing Quarterly report (10-Q)
- 2023-10-13 filing 8-K items 8.01,9.01
- 2023-09-21 filing 8-K items 8.01,9.01
- 2023-09-06 filing 8-K items 8.01,9.01
- 2023-08-03 filing 8-K items 2.02,9.01
- 2023-08-03 filing Quarterly report (10-Q)
- 2023-07-24 filing UPLOAD
- 2023-07-07 filing CORRESP
- 2023-06-26 filing UPLOAD
- 2023-06-23 filing 8-K items 5.07
- 2023-05-31 filing CORRESP
- 2023-05-11 filing 8-K items 2.02,9.01
- 2023-05-11 filing Quarterly report (10-Q)
- 2023-04-28 filing UPLOAD
- 2023-04-27 filing ARS
- 2023-04-27 filing DEFA14A
- 2023-04-27 filing Proxy statement
- 2023-03-23 filing S-8
- 2023-03-23 filing 8-K items 2.02,9.01
- 2023-03-23 filing Annual report (10-K)
- 2023-03-06 filing 8-K items 8.01,9.01
- 2023-03-06 filing 424B5
- 2023-03-06 filing 424B5
- 2023-03-02 filing 8-K items 2.02,8.01
- 2023-03-02 filing 424B5
- 2023-03-02 filing 424B5
- 2023-03-01 filing 8-K items 8.01
- 2023-02-14 filing 8-K items 8.01,9.01
- 2022-12-16 filing 8-K items 5.07
- 2022-11-29 filing DEFA14A
- 2022-11-10 filing Proxy statement
- 2022-11-03 filing 8-K items 2.02,9.01
- 2022-11-03 filing Quarterly report (10-Q)
- 2022-10-31 filing PRE 14A
- 2022-10-21 filing 8-K items 8.01
- 2022-09-08 officer change 8-K items 5.02
- 2022-09-02 filing 8-K items 3.01
- 2022-08-09 filing 8-K items 2.02,9.01
- 2022-08-09 filing Quarterly report (10-Q)
- 2022-07-27 filing 8-K items 1.01,8.01
- 2022-07-07 filing 8-K items 8.01,9.01
- 2022-06-24 filing 8-K items 5.07
- 2022-05-11 filing 8-K items 2.02,9.01
- 2022-05-11 filing Quarterly report (10-Q)
- 2022-04-29 filing DEFA14A
- 2022-04-29 filing Proxy statement
- 2022-04-04 officer change 8-K items 5.02
- 2022-03-07 filing S-8
- 2022-03-07 filing 8-K items 2.02,9.01
- 2022-03-07 filing Annual report (10-K)
- 2022-03-04 filing 8-K items 3.01
- 2021-12-14 filing 8-K items 7.01,8.01,9.01
- 2021-11-22 filing EFFECT
- 2021-11-18 filing CORRESP
- 2021-11-17 filing UPLOAD
- 2021-11-10 filing S-3
- 2021-11-10 filing 8-K items 2.02,9.01
- 2021-11-10 filing Quarterly report (10-Q)
- 2021-10-08 filing 8-K items 8.01,9.01
- 2021-10-08 filing 424B5
- 2021-10-08 filing 424B5
- 2021-10-07 filing 424B5
- 2021-10-07 filing 424B5
- 2021-09-21 filing 8-K items 8.01,9.01
- 2021-09-01 officer change 8-K items 5.02
- 2021-08-31 filing S-8
- 2021-08-17 filing 8-K items 7.01,8.01,9.01
- 2021-08-12 filing 8-K items 2.02,9.01
- 2021-08-12 filing Quarterly report (10-Q)
- 2021-08-12 filing SC 13D/A
- 2021-07-20 officer change 8-K items 5.02
- 2021-07-01 officer change 8-K items 5.02
- 2021-06-24 filing 8-K items 5.07
- 2021-05-17 filing 8-K items 8.01
- 2021-05-13 filing 8-K items 2.02,9.01
- 2021-05-13 filing Quarterly report (10-Q)
- 2021-04-28 filing DEFA14A
- 2015-02-04 name change Name changed from K2 THERAPEUTICS, INC.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-01-20 (older) 15-12G filed
- 2026-01-09 (older) EFFECT filed
- 2026-01-09 (older) EFFECT filed
- 2026-01-09 (older) EFFECT filed
- 2026-01-09 (older) EFFECT filed
- 2026-01-09 (older) EFFECT filed
- 2026-01-09 (older) EFFECT filed
- 2026-01-07 (older) S-8 POS filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- No listing symbol is held for this company.
- Open in
Open in…
Insider trades
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1610618 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| EIN | 461537286 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001610618 | SEC EDGAR / IRS |
The company table did not answer, so only the identifiers carried on the SEC record are shown.
Next: reload in a minute, or open the record page.
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2024-12-31) | $1,275,000 | 2024-12-31 | 10-K, XBRL Revenues | as filed | 2026-11-22 03:04 UTC | Report an error |
| Net income (loss) (fiscal year ended 2024-12-31) | -$169,827,000 | 2024-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 03:04 UTC | Report an error |
| Total assets (at 2024-12-31) | $214,796,000 | 2024-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 03:04 UTC | Report an error |
| Stockholders' equity (at 2024-12-31) | $163,308,000 | 2024-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 03:04 UTC | Report an error |
| Cash and cash equivalents (at 2024-12-31) | $189,825,000 | 2024-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 03:04 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-02-17 | SEC EDGAR company profile | as filed | 2026-11-22 03:04 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-02-17 | SEC EDGAR company profile | as filed | 2026-11-22 03:04 UTC | Report an error |
| State of incorporation | DE | 2026-02-17 | SEC EDGAR company profile | as filed | 2026-11-22 03:04 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-02-17 | SEC EDGAR company profile | as filed | 2026-11-22 03:04 UTC | Report an error |
| Business address | 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA, 92121 | 2026-02-17 | SEC EDGAR company profile | as filed | 2026-11-22 03:04 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2024-12-31) | -$176,533,000 | 2024-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-22 03:04 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31) | $129,000 | 2024-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-22 03:04 UTC | Report an error |
| Operating lease liabilities (at 2024-12-31) | $3,002,000 | 2024-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-22 03:04 UTC | Report an error |
| Form D total offering amount (D filed 2024-05-06) | $240,000,000 | 2024-05-06 | D | as filed | 2026-11-22 03:04 UTC | Report an error |
| Form D total amount sold (D filed 2024-05-06) | $240,000,000 | 2024-05-06 | D | as filed | 2026-11-22 03:04 UTC | Report an error |
| Form D industry group | Biotechnology | 2024-05-06 | D | as filed | 2026-11-22 03:04 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2024-05-06 | D | as filed | 2026-11-22 03:04 UTC | Report an error |
| Form D date of first sale | 2024-04-24 | 2024-05-06 | D | as filed | 2026-11-22 03:04 UTC | Report an error |
Latest report: 10-Q for the period ended 2025-09-30, filed 2025-11-06 · accession 0001610618-25-000096
Old data: the newest 10-Q or 10-K in SEC company facts has no later XBRL values.
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | 3 months ended 2025-09-30 | 10-Q | 2025-11-06 | 0001610618-25-000096 | 2026-11-22 03:04 UTC | Report an error |
| Net income (loss) | -$83,233,000 | 3 months ended 2025-09-30 | 10-Q | 2025-11-06 | 0001610618-25-000096 | 2026-11-22 03:04 UTC | Report an error |
| Cash and cash equivalents | $293,651,000 | at 2025-09-30 | 10-Q | 2025-11-06 | 0001610618-25-000096 | 2026-11-22 03:04 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-01-20 Filing 15-12G filed
- 2026-01-09 Filing EFFECT filed
- 2026-01-09 Filing EFFECT filed
- 2026-01-09 Filing EFFECT filed
- 2026-01-09 Filing EFFECT filed
- 2026-01-09 Filing EFFECT filed
- 2026-01-09 Filing EFFECT filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing S-8 POS filed
- 2026-01-07 Filing POS AM filed
- 2026-01-07 Filing POS AM filed
- 2026-01-07 Filing POS AM filed
- 2026-01-07 Filing POS AM filed
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1610618.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001610618. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.